KR102410619B9 - 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 - Google Patents
오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물Info
- Publication number
- KR102410619B9 KR102410619B9 KR1020220051499A KR20220051499A KR102410619B9 KR 102410619 B9 KR102410619 B9 KR 102410619B9 KR 1020220051499 A KR1020220051499 A KR 1020220051499A KR 20220051499 A KR20220051499 A KR 20220051499A KR 102410619 B9 KR102410619 B9 KR 102410619B9
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- treating
- composition
- related disorder
- isolated compound
- Prior art date
Links
- 241000219495 Betulaceae Species 0.000 title 1
- 229940125904 compound 1 Drugs 0.000 title 1
- 210000003205 muscle Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220051499A KR102410619B1 (ko) | 2020-08-11 | 2022-04-26 | 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200100747A KR102424758B1 (ko) | 2020-08-11 | 2020-08-11 | 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
KR1020220051499A KR102410619B1 (ko) | 2020-08-11 | 2022-04-26 | 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200100747A Division KR102424758B1 (ko) | 2020-08-11 | 2020-08-11 | 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
KR20220061070A KR20220061070A (ko) | 2022-05-12 |
KR102410619B1 KR102410619B1 (ko) | 2022-06-22 |
KR102410619B9 true KR102410619B9 (ko) | 2023-04-12 |
Family
ID=80246777
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200100747A KR102424758B1 (ko) | 2020-08-11 | 2020-08-11 | 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
KR1020220051499A KR102410619B1 (ko) | 2020-08-11 | 2022-04-26 | 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
KR1020220083246A KR102432796B1 (ko) | 2020-08-11 | 2022-07-06 | 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
KR1020220083247A KR102432797B1 (ko) | 2020-08-11 | 2022-07-06 | 오리나무 추출물로부터 분리된 화합물 3-5를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200100747A KR102424758B1 (ko) | 2020-08-11 | 2020-08-11 | 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220083246A KR102432796B1 (ko) | 2020-08-11 | 2022-07-06 | 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
KR1020220083247A KR102432797B1 (ko) | 2020-08-11 | 2022-07-06 | 오리나무 추출물로부터 분리된 화합물 3-5를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20230270805A1 (ko) |
KR (4) | KR102424758B1 (ko) |
WO (1) | WO2022035115A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102645399B1 (ko) | 2022-07-25 | 2024-03-11 | 코스맥스엔에스 주식회사 | 유스카픽 에시드를 포함하는 근 기능 개선 또는 근육 질환 예방, 개선 또는 치료용 조성물 |
KR102487069B1 (ko) | 2022-10-17 | 2023-01-10 | 이주연 | 황백, 오리나무 및 회향을 포함하는 혼합물의 이중 복합 추출물을 포함하는 항바이러스용 조성물 |
KR102555401B1 (ko) | 2023-01-05 | 2023-07-13 | 이주연 | 황백, 오리나무 및 회향을 포함하는 혼합물의 이중 복합 추출물을 포함하는 코로나 바이러스 억제용 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100950428B1 (ko) * | 2008-06-05 | 2010-04-02 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물 |
KR100987303B1 (ko) * | 2009-12-14 | 2010-10-12 | 주식회사 알앤엘바이오 | 오리나무 유래 디아릴헵타노이드계 화합물을 포함하는 항산화 및 간보호용 조성물 |
KR20120089118A (ko) * | 2011-02-01 | 2012-08-09 | 주식회사 엘컴사이언스 | 오리나무 추출물 또는 그로부터 분리된 화합물을 유효성분으로 포함하는 간 섬유화 억제용 조성물 |
KR101310285B1 (ko) * | 2011-10-12 | 2013-09-24 | 심재종 | 산청목, 오리목, 포공영, 대계, 창이자, 갈화, 지구목 및 갈근을 유효성분으로 함유하는 뇌질환 예방 또는 치료용 약학적 조성물 |
KR20180131770A (ko) * | 2017-06-01 | 2018-12-11 | 숙명여자대학교산학협력단 | 황련 추출물을 함유하는 근육관련 질환의 예방 및 치료용 조성물 |
KR102205634B1 (ko) * | 2019-01-11 | 2021-01-21 | 주식회사 에코프로 | 폼멜트가 접착된 케미컬 필터, 그 제조방법 및 그 제조장치 |
-
2020
- 2020-08-11 KR KR1020200100747A patent/KR102424758B1/ko active IP Right Grant
-
2021
- 2021-08-03 WO PCT/KR2021/010158 patent/WO2022035115A1/ko active Application Filing
- 2021-08-03 US US18/018,473 patent/US20230270805A1/en active Pending
-
2022
- 2022-04-26 KR KR1020220051499A patent/KR102410619B1/ko active IP Right Grant
- 2022-07-06 KR KR1020220083246A patent/KR102432796B1/ko active IP Right Grant
- 2022-07-06 KR KR1020220083247A patent/KR102432797B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2022035115A1 (ko) | 2022-02-17 |
US20230270805A1 (en) | 2023-08-31 |
KR20220102600A (ko) | 2022-07-20 |
KR102432797B9 (ko) | 2023-04-12 |
KR102432796B9 (ko) | 2023-04-12 |
KR102432797B1 (ko) | 2022-08-16 |
KR102410619B1 (ko) | 2022-06-22 |
KR20220101588A (ko) | 2022-07-19 |
KR102424758B1 (ko) | 2022-07-26 |
KR102424758B9 (ko) | 2023-04-12 |
KR20220061070A (ko) | 2022-05-12 |
KR102432796B1 (ko) | 2022-08-16 |
KR20220020477A (ko) | 2022-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102432796B9 (ko) | 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 | |
AU2018238202A8 (en) | Combination therapy for the treatment or prevention of tumours | |
WO2016154016A3 (en) | Tat-induced crispr/endonuclease-based gene editing | |
NZ746554A (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
MX2023000025A (es) | Inhibidores de la quinasa progenitora hematopoyética 1 y usos de estos. | |
IL288480A (en) | A method of protecting items from decomposition and decay | |
ZA202100485B (en) | Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same | |
EP3806862A4 (en) | METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING THE PROGRESSION AND/OR ONSET OF AGE-RELATED NEURODEGENERATION | |
JOP20210158A1 (ar) | مُعَدِّلات التعبير الجيني عن hsd17b13 | |
WO2018044937A3 (en) | Compositions and methods for treating a tumor suppressor deficient cancer | |
KR20180084610A (ko) | 신생아 hie 치료용 조성물 | |
WO2018183370A3 (en) | Kdm4 inhibitors | |
WO2020252229A3 (en) | Inhibitors of sarm1 | |
IL308221A (en) | Preparations and methods for treating depression | |
EP4014978A8 (en) | Combination product containing limonoid and alpha-glucosidase inhibitor | |
IL277332A (en) | Preparations and methods for treating severe constipation | |
EP3790565A4 (en) | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING GUT BARRIER DYSFUNCTION | |
IL311199A (en) | Compounds and formulations for protective coatings | |
EP4058043A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN’S DISEASE | |
EP4007610A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF ALPHA-THALASSEMIA | |
WO2020185651A3 (en) | Compositions and methods for treating huntington's disease | |
KR102373488B9 (ko) | 면역활성 또는 암의 예방 또는 치료용 의약 조성물 | |
WO2020032885A3 (en) | Capsule-in-capsule compositions of dabigatran etexilate | |
GB202005986D0 (en) | Methods and compositions for treating and combatting tuberulosis | |
AU2018266835A1 (en) | Antioxidant dietary supplement compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |